THE HEALTH CORPORATION - RAMBAM

logo

  Haaliya 8 – Haifa – 31096

  VAT: nan

   http://www.rambam.org.il/home+page/


Complicit EU Projects



  Within the Horizon 2020 (2014-2020) framework, THE HEALTH CORPORATION - RAMBAM has received € 273,408.0 for its participation in a total of 2 project(s) with a total cost of € 37,433,215.

Start (YYYYMMDD) Project ID Project Name Themes End (YYYYMMDD) Role EC Contribution Total Cost IL Participation Total Participation CORDIS Link
2019-04-01 820755 VALUE-Dx public health  ·  antibiotics  ·  antibiotic resistance 2024-09-30 participant € 88,408.87 € 14,125,707 1 27 CORDIS ↪
2020-01-01 847999 PROFID software  ·  public health 2024-12-31 participant € 185,000.0 € 23,307,508 1 26 CORDIS ↪

  Within the Horizon Europe (2021-2027) framework, THE HEALTH CORPORATION - RAMBAM has received € 422,500.0 for its participation in a total of 2 project(s) with a total cost of € 17,387,271.

Start (YYYYMMDD) Project ID Project Name Themes End (YYYYMMDD) Role EC Contribution Total Cost IL Participation Total Participation CORDIS Link
2022-09-01 101057821 RELEVIUM nutrition  ·  pancreatic cancer  ·  ultrasound 2026-08-31 participant € 215,000.0 € 5,997,312 1 18 CORDIS ↪
2024-01-01 101136670 GLIOMATCH oncology  ·  personalized medicine  ·  machine learning 2028-12-31 participant € 207,500.0 € 11,389,958 1 15 CORDIS ↪

  Within the FP7 (2007-2013) framework, THE HEALTH CORPORATION - RAMBAM has received € 1,339,468.0 for its participation in a total of 5 project(s) with a total cost of € 125,932,495.

Start (YYYYMMDD) Project ID Project Name Themes End (YYYYMMDD) Role EC Contribution Total Cost IL Participation Total Participation CORDIS Link
2014-12-01 618174 PASCAL DNA  ·  oncology 2018-11-30 coordinator € 100,000.0 € 100,000 1 1 CORDIS ↪
2012-07-01 303426 ENIGMA cell biology  ·  cardiology  ·  enzymes  ·  molecular biology 2016-06-30 coordinator € 100,000.0 € 100,000 1 1 CORDIS ↪
2011-12-01 278348 AIDA public health  ·  urology  ·  antibiotics  ·  pharmacokinetics  ·  multidrug resistance 2017-11-30 participant € 465,385.0 € 7,768,103 3 19 CORDIS ↪
2015-03-01 115620 COMBACTE-CARE bacteriology  ·  epidemics prevention  ·  antibiotics  ·  multidrug resistance  ·  antibiotic resistance 2020-02-28 participant € 522,200.0 € 85,113,336 2 23 CORDIS ↪
2012-03-01 115303 ABIRISK rheumatology  ·  databases  ·  immunisation  ·  multiple sclerosis  ·  gastroenterology 2018-02-28 participant € 151,883.0 € 32,851,056 2 38 CORDIS ↪